Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

4 Stocks To Keep An Eye On: ABUS, COOL, ECYT, HEAR

Published 08/02/2018, 12:41 AM
Updated 07/09/2023, 06:31 AM

Arbutus Biopharma Corp (NASDAQ:ABUS) is a swing trade we’ve been talking about. Up 75 cents, or 6 3/4%, on Wednesday, to 11.85, on 450,467 shares. You can see the run up it had, now this nice consolidation. Support around 10.30, resistance around 12, 12-05. If we get through that level, and blow through that line, that major trend shallow top, we could explode right to 15. This looks interesting. Keep an eye on it.

PolarityTE Inc (NASDAQ:COOL) is up 10 cents, or 44%, on Wednesday, to 22.89, on 478,000 shares. After the big pop, the resistance, and pull back, a little coil developed. It broke out 2 days in a row, up again, not much today, but enough for me to say I think it’s got momentum to get it up to test and take out 26 1/4. If that occurs, 29 and 33 are targets.

Endocyte Inc (NASDAQ:ECYT) swing trade continues to work. From about the April range when it was about 9 or 10, its moved up to as high as the high teens, near 18, 17.69. Up 96 cents, or 6%, to 16.28, on 1 million shares. It pulled back, tagged the top bottom of the channel, and snapped back. It had a nice tail on Tuesday and another follow through day on Wednesday. I like it. A little bit of resistance now, about 17, and the double top at 17 3/4. These are the levels you want to watch going forward. If we get through that, I’m looking for 19 and 21.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Turtle Beach Corp (NASDAQ:HEAR) is up another 96 cents, or 3 1/2%, to 28.15, on 1.5 million shares on Wednesday, but more importantly, it’s had a 6-day high. I think it might challenge the recent high of 30 and take that out and run up to 32 – 2 ½. Long term though, mid 40’s.

Stocks on the long side included Arbutus Biopharma Corporation (ABUS), Endocyte, Inc. (ECYT), ArQule, Inc. (ARQL), SodaStream International LTD. (SODA), Paycom Software, Inc. (PAYC), Kirkland Lake Gold Ltd. (KL), Tandem Diabetes Care, Inc. (TNDM), PolarityTE, Inc. (COOL), Libbey Inc. (LBY), Turtle Beach Corporation (HEAR), The Container Store Group, Inc. (TCS), CAI International, Inc. (CAI), Nanometrics Incorporated (NANO), Health Insurance Innovations, Inc. (HIIQ), Intelsat S.A. (I), Natera, Inc. (NTRA), CareDx, Inc. (CDNA), NII Holdings, Inc. (NIHD), and Unisys Corporation (UIS).

Watch video here.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.